X-7050303-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_012080.5(PUDP):āc.680A>Gā(p.Tyr227Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000538 in 1,208,319 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000045 ( 0 hom., 0 hem., cov: 24)
Exomes š: 0.000055 ( 0 hom. 17 hem. )
Consequence
PUDP
NM_012080.5 missense
NM_012080.5 missense
Scores
4
1
12
Clinical Significance
Conservation
PhyloP100: 0.470
Genes affected
PUDP (HGNC:16818): (pseudouridine 5'-phosphatase) This gene encodes a member of the haloacid dehalogenase-like (HAD) hydrolase superfamily. The encoded protein has no known biological function. This gene has a pseudogene on chromosome 1. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10856435).
BS2
High Hemizygotes in GnomAdExome4 at 17 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PUDP | NM_012080.5 | c.680A>G | p.Tyr227Cys | missense_variant | 4/4 | ENST00000381077.10 | NP_036212.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PUDP | ENST00000381077.10 | c.680A>G | p.Tyr227Cys | missense_variant | 4/4 | 1 | NM_012080.5 | ENSP00000370467.6 | ||
PUDP | ENST00000424830.6 | c.749A>G | p.Tyr250Cys | missense_variant | 5/5 | 3 | ENSP00000396452.2 | |||
PUDP | ENST00000412827.6 | c.551A>G | p.Tyr184Cys | missense_variant | 4/4 | 2 | ENSP00000406260.2 | |||
PUDP | ENST00000655425.1 | n.204+26917A>G | intron_variant | ENSP00000499460.1 |
Frequencies
GnomAD3 genomes AF: 0.0000447 AC: 5AN: 111767Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33965
GnomAD3 genomes
AF:
AC:
5
AN:
111767
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
33965
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000890 AC: 16AN: 179746Hom.: 0 AF XY: 0.0000911 AC XY: 6AN XY: 65882
GnomAD3 exomes
AF:
AC:
16
AN:
179746
Hom.:
AF XY:
AC XY:
6
AN XY:
65882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000547 AC: 60AN: 1096499Hom.: 0 Cov.: 30 AF XY: 0.0000470 AC XY: 17AN XY: 362011
GnomAD4 exome
AF:
AC:
60
AN:
1096499
Hom.:
Cov.:
30
AF XY:
AC XY:
17
AN XY:
362011
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000447 AC: 5AN: 111820Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34028
GnomAD4 genome
AF:
AC:
5
AN:
111820
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
34028
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.749A>G (p.Y250C) alteration is located in exon 5 (coding exon 5) of the PUDP gene. This alteration results from a A to G substitution at nucleotide position 749, causing the tyrosine (Y) at amino acid position 250 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Benign
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;.
Vest4
MVP
MPC
0.16
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at